About us

Retatrutide SA is an independent information site for readers in South Africa who want to understand retatrutide: what it is, where the research stands, how it is regulated, and how the sellers offering it online compare.

Why this site exists

Retatrutide is an investigational medicine. It is still in clinical trials and is not registered by SAHPRA, the South African health regulator. That has not stopped it from being offered online, often with confident claims and very little information about who is selling it or where it comes from. People who are curious about it, or who have already been offered it, struggle to find plain facts.

We started this site to put those facts in one place: what the trials have shown so far, what the regulator has said, and what sellers actually publish about themselves. We want you to be able to read it, check our sources and decide for yourself.

What you will find here

Our seller ratings compare 25 online sellers on the same six points, so you can see which ones are open about their lab reports, their business and their delivery terms. Our articles cover the research, the rules and the news, each one with its sources and dates listed at the bottom, and they are grouped by topic so you can find what you need.

Every rating and every article follows the same published rules. You can read them in how we rate, and see how we handle sources and mistakes in our editorial policy.

What we do not do

We don't sell retatrutide or any other product, and we don't take money from sellers. We don't give medical advice, doses or treatment plans, and we don't encourage anyone to buy or use a medicine that is not registered. We also don't test products ourselves, so a high rating tells you that a seller is open and organised. It does not tell you that a product is safe, genuine or effective.

Who it is for

This site is for anyone in South Africa who wants clear, sourced information: people thinking about their own health, family members who are worried, journalists, pharmacists and other professionals. If you are making a decision about your health, please talk to a doctor or pharmacist first. SAHPRA has published public information on peptide products that we recommend reading.

Who is behind the site

The editor-in-chief of Retatrutide SA is Clark William Brown. Education: University of Pretoria; Colleges of Medicine of South Africa. The way we research, check and publish, described in our editorial policy, is set up and approved by the editor-in-chief and the project team.

Get in touch

If you spot a mistake, have a question about a rating or have information to share, write to editor@retatrutidesouthafrica.co.za. We read everything.